Big Pharma pushes new migraine drugs into Phase III with blockbuster hopes

Damian Garde A cadre of drugmakers is pressing toward late-stage trials with new injectable treatments in the long-stagnant field of migraine therapy, racing to capitalize on what analysts ...

‘Modern Family’ star signs on with BMS for immuno-oncology awareness

Carly Helfand Pharma-watchers may be very familiar with immuno-oncology. But the average American doesn't necessarily know what the term means–or why it's important. Bring ...

Apogenix inks cancer drug development deal for China

John Carroll Germany's Apogenix, which is backed by SAP co-founder Dietmar Hopp, has struck an exclusive licensing agreement with CANbridge Life Sciences to develop and commercialize ...

Playing catch-up on Big Biotech goal, Shire broadens M&A focus

Carly Helfand Shire's $ 54 billion tie-up with AbbVie–and the subsequent cancellation of that deal–shook up employees and stalled CEO Flemming Ornskov's plans to ...

UPDATED: Celgene chief Bob Hugin isn’t done betting on ‘binary’ biotech deals

John Carroll By all accounts, the bidding war for Receptos was intense. But for Celgene CEO Bob Hugin and his go-to deals chief George Golumbeski, strategically this was exactly the ...

Look out, Teva–Novartis’ Copaxone generic is off to a speedy start

Carly Helfand The launch for Glatopa, the new generic of Teva's Copaxone from Novartis' Sandoz, is still in the very early going. But so far, things look good–very good. FiercePharma ...

Biotech legend Lee Hood gambles $36M on a plan to revolutionize healthcare

John Carroll FierceBiotech News

DOJ criminal probe takes a look at trade associations

Eric Palmer For more than a year, the Justice Department (DOJ) has been pursuing a criminal investigation into the possibility of pricing collusion among makers of generics. Three companies ...

GlaxoSmithKline and Purdue look to Apple’s ResearchKit for R&D

Damian Garde ResearchKit, the technology Apple promises will transform the world's hundreds of millions of iPhones into handheld gatherers of clinical data, could become a viable ...

Takeda chairman Hasegawa out as JPMA vice president

Alok Saboo FierceBiotech News

FDA scales up CV warnings on NSAIDs

Carly Helfand The FDA already had a warning out about the cardiovascular safety of nonsteroidal anti-inflammatory drugs, or NSAIDs. But on Thursday, it strengthened that warning for ...

House passes 21st Century Cures bill

Eric Palmer Members of U.S. House of Representatives voted 344 to 77 today to approve the 21st Century Cures bill. It now goes to the Senate for consideration. The bill provides more ...
Page 3 of 512345
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS